LYRA vs SBAC · rev $1.5M vs P/E 30, rev $1.42B
Lyra Therapeutics Inc (LYRA) versus SBA Communications Corp (SBAC) — a side-by-side from cached financials, not a winner call.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
SBA Communications Corp (SBAC) is a reit - specialty company listed on US.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
Latest reported SBAC revenue for 2026-06-30 was $1.42B. Net income was $383.6M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
LYRA currently screens at market cap $14.4M. SBAC currently screens at market cap $24.58B and trailing P/E 30.3.
Not investment advice. Open the LYRA and SBAC stock pages for the full models.
Not investment advice.